Hepatitis B virus infections in families in which the
Takegoshi Internal Medicine Clinic, 377-7 Nomura, Takaoka, Toyama 933-0014, JapanDepartment of Pathology, Tangdu Hospital, the Fourth Military Medical University, Xi’an, Shaanxi 710038, China
Received 11 July 2005; received in revised form 10 November 2005; accepted 8 June 2006
Abstract
We studied a total of 37 families, in which HBsAg was positive in either or both of father and mother, to assess intra-familial transmission
of hepatitis B virus (HBV). The HBsAg positive rate for children with HBsAg-negative mothers was significantly lower than that with
positive mothers (4 of 31, 12.9% versus 18 of 32, 56.3%, p < 0.01) of course. However, there were three families in which the infection
source for children was thought to be fathers, not mothers, i.e., of eight children in these three families with HBsAg +/− father/mother pairs,
4 (50%) were positive for both HBsAg and HBV DNA of genotypes identical to those of their fathers, and another child was positive for
HBcAb despite being negative for HBsAg. Interestingly, moreover, all the mothers in these three families were HBcAb-positive even though
HBsAg-negative, suggesting that not only father-to-child but also inter-spouse HBV transmission might have occurred. With these findings we
would suggest that all the family members with HBsAg-positive fathers should receive HBV vaccine, let alone for those with HBsAg-positive
2006 Published by Elsevier Ireland Ltd. Keywords: Hepatitis B virus; Intra-familial transmission; Vaccine
1. Introduction
is very low However, intra-familial transmission of
HBV, especially from fathers to children, was evidenced by
The majority of chronic hepatitis B virus (HBV) infec-
tions occur during early childhood and transmission of
The aim of the present study was to assess hepatitis B
HBV from an HBsAg-positive mother to her infant during or
virus (HBV) infection from fathers to children in families
just after birth results in the highest risk (70–90%) of persis-
tent infection in countries of intermediate to high endemicity
In Japan, all infants born to HBeAg-positive mothers
have been receiving the HBV vaccine since 1985 As a
2. Materials and methods
result, the prevalence of chronic HBV infection at the age of
14–19 years has decreased to 0.44%, whereas chronic HBV
infection at the age of 40–49 still affected as high a number as
1.46% in 1996 t is reported that the rate of HBV infec-
Enrolled, in this study, were 127 individuals in 37 fam-
tion for children in families with HBsAg-negative mothers
ilies (15 fathers, ages 39–67; 37 mothers, ages 37–80; 75
children, ages 10–56, males/females = 38/37) who had vis-
ited Takegoshi Internal Medicine Clinic during the past 14
E-mail address: (K. Takegoshi).
years. HBsAg status of the father/mother pairs in these fami-
1386-6346/$ – see front matter 2006 Published by Elsevier Ireland Ltd. K. Takegoshi, W. Zhang / Hepatology Research xxx (2006) xxx–xxx
lies was +/− in 14 families (category 1), +/− in 22 (categories
3. Results
2 and 3), and +/+ in 1 (category 4). In the father/mother +/−
group, children of four families had been vaccinated (cat-
3.1. Children in the families with HBsAg-positive
egory 2) while those of the other 18 families unvaccinated
As depicted synoptically in the children in the
families with HBsAg-positive mothers, if not protected by
vaccine, were more prone to HBV infection as compared to
those in the families with HBsAg-negative mothers: HBsAg
All serum samples were tested for HBV and HCV serolog-
positive rate was 59% (20/34) in the children of category
ical markers using commercially available immunoassays,
3 + 4, whereas it was only 13% (4/31) in those of category 1
ARCHITECT® (Dinabot Co., Ltd.) and a Cobas R Core
anti-HCV EIA kit (Roche Diagnostics GmbH, Mannheim,
Germany), respectively. Informed consent was obtained from
each individual, and the protocol of study conformed to the
3.2. Children in the families where mothers were
ethical guidelines of the 1975 Declaration of Helsinki. negative but fathers were positive for HBsAg2.3. HBV genotyping and sequencing
Among the 37 families studied, there were three fami-
lies in which one or more children were HBsAg-positive
HBV genotypes were determined serologically by ELISA
although their mothers were HBsAg-negative. As shown in
with monoclonal antibodies for type-specific epitopes in the
the lower part of HBsAg tested positive in the father
preS2-region (Institute of Immunology, Co., Ltd.)
and two of his four children but not in his wife in the family
A fragment of HBV DNA of nt positions from 1445 to
A. Similarly, in the families B and C, the fathers and one of
2157 was PCR-amplified by previously reported methods
their respective children were positive but their wives were
PCR products were then subjected to direct sequenc-
negative for HBsAg. Identical HBV genotypes were shared
ing with use of ABI PRISM 377 DNA sequencer (Applied
between father and child, respectively, i.e., genotype B in the
Biosystems, Foster City, CA). Nucleotide data analyses were
family A while genotype C in the families B and C. Sequence
done with GENETYX® 6.0 (Genetyx Co., Tokyo, Japan).
analyses also supported the closeness of HBV strains within
Fig. 1. Synopsis of the study results. Box and circle represent male and female, respectively. HBsAg-positive individuals were indicated by black-daubed boxesor circles, while those with HBcAb by gray ones. White characters on a black background of the boxes and circles indicate HBV genotypes. K. Takegoshi, W. Zhang / Hepatology Research xxx (2006) xxx–xxx
each pair of father and child (data not shown here). Inter-
Acknowledgements
estingly, all the mothers in these three families and a child
in the family C were positive for antibodies against HBV
The authors thank Prof. Claus H. Schroeder (Deutsches
core antigen (HBcAb) despite being negative for HBsAg, an
Krebsforschungzentrum) for critical comments, Dr. Mal-
evidence for cryptic HBV infection or past exposure to it
colm Moore and Dr. Kevin Keane for critical reading of the
manuscript, and Dr. Toshio Matsui for advice on nucleotide
4. Discussion References
Franks et al. that the father-to-child HBV
[1] Margolis HS, Alter MJ, Hadler SC. Hepatitis B: evolving epidemi-
transmission rate was 9.4%, and our present result (13% in
ology and implications for control. Semin Liver Dis 1991;11:84–92.
view of HBsAg) almost corroborates this figure. However,
[2] Xu ZY, Liu CB, Francis DP, et al. Prevention of perinatal acquisition
it is noteworthy that these figures may still underestimate
of hepatitis B virus carriage using vaccine: preliminary report of a
randomized, double-blind placebo-controlled and comparative trial.
the actual risk of father-to-child transmission, because, as
exemplified by the second child of the family C in
[3] Oda T. Viral hepatitis and hepatocellular carcinoma prevention strat-
there might exist additional cases of infection, unnoticed
egy in Japan. Jpn J Cancer Res 1999;90:1051–60.
by being negative for HBsAg although being positive for
[4] Yoshizawa K. A trend of HBV carrier in Japan. In: Kanngann-
Hakusho. Tokyo: Jap Soc Hepatol; 1999, 23–32, (in Japanese).
[5] Franks AL, Berg CJ, Kane MA, et al. Hepatitis B virus infection
The importance of HBsAg-positive father as a possible
among children born in the United States to Southeast Asian refuges.
source of HBV infection within a family was also under-
scored by the finding that all the mothers in the families
[6] Stevens CE, Beasley P, Tsui J, Lee WC. Vertical transmission of
A–C were HBcAb-positive even though HBsAg-negative.
hepatitis B antigen in Taiwan. N Engl J Med 1975;292:771–4.
Such inter-spouse HBV transmission could easily be under-
[7] Lin HJ, Lai CL, Lau JYN, et al. Evidence for intrafamilial trans-
mission of hepatitis B virus from sequence analysis of mutant HBV
stood because HBV is a sexually transmitted virus. Thus,
DNAs in two Chinese families. Lancet 1990;336:208–12.
it could be speculated that the apparent “father-to-child”
[8] Lin HJ, Lai CL, Lauder IJ, et al. Application of hepatitis B virus
HBV transmission in these families might indeed have been
(HBV) DNA sequence polymorphisms to the study of HBV trans-
a “father-to-mother-to-child” transmission, because the con-
mission. J Infect Dis 1991;164:284–8.
tact between mother and child must have been much closer
[9] Usuda S, Okamoto H, Iwanari H, et al. Serological detection of
hepatitis B virus genotypes by ELISA with monoclonal antibodies
to type-specific epitopes in the preS2-region product. J Virol Methods
In conclusion, our present results strongly support the
notion that all the family members with HBsAg-positive
[10] Zhang W, Hacker HJ, Tokus M, Bock T, Schroeder CH. Patterns of
fathers should receive HBV vaccine, let alone for those with
circulating hepatitis B virus serum nucleic acids during lamivudine
therapy. J Med Virol 2003;71:24–30.
Federal preemption is an important defense available to drug manufacturers defending product liability lawsuits. The question of whether certain federal laws conflict with and preempt state laws is a highly litigated one. Courts throughout the country continue to address the issue and their decisions bear monitoring. This article highlights some key preemption opinions issued in the pharma
Practice Guidelines ACOG Releases Guidelines for Clinical Management of Osteoporosis The American College of Obstetricians and Gynecologists (ACOG) recently issued guidelines for the clinical management of osteoporosis in women, including recommendations for screening, prevention, and treatment of this condition. The guidelines appeared in the January 2004 issue of Obstetrics and Gynecol